Advanced imaging to assess longitudinal vascular changes in brain metastases treated with checkpoint inhibition.

被引:0
|
作者
Kim, Albert Eusik
Chang, Ken
Emblem, Kyrre E.
Kalpathy-Cramer, Jayashree
Lee, Eudocia Quant
Lin, Nancy U.
Tolaney, Sara M.
Nayak, Lakshmi
Chukwueke, Ugonma Nnenna
Oh, Kevin S.
Shih, Helen Alice
White, Michael
Lawrence, Don P.
Moy, Beverly
Cohen, Justine Vanessa
Giobbie-Hurder, Anita
Cahill, Daniel P.
Sullivan, Ryan J.
Brastianos, Priscilla Kaliopi
Gerstner, Elizabeth Robins
机构
[1] Massachusetts Gen Hosp, Boston, MA 02114 USA
[2] Athinoula A Martinos Ctr Biomed Imaging, Charlestown, MA USA
[3] AA Martinos Ctr Biomed Imaging, Boston, MA USA
[4] Dana Farber Canc Inst, Boston, MA 02115 USA
[5] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA
[6] Massachusetts Gen Hosp, Ctr Canc, Boston, MA USA
[7] Harvard Med Sch, Boston, MA 02115 USA
关键词
D O I
10.1200/JCO.2021.39.15_suppl.3059
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
3059
引用
收藏
页数:2
相关论文
共 50 条
  • [21] Microenvironmental Landscape of Human Melanoma Brain Metastases in Response to Immune Checkpoint Inhibition
    Alvarez-Breckenridge, Christopher
    Markson, Samuel C.
    Stocking, Jackson H.
    Nayyar, Naema
    Lastrapes, Matt
    Strickland, Matthew R.
    Kim, Albert E.
    de Sauvage, Magali
    Dahal, Ashish
    Larson, Juliana M.
    Mora, Joana L.
    Navia, Andrew W.
    Klein, Robert H.
    Kuter, Benjamin M.
    Gill, Corey M.
    Bertalan, Mia
    Shaw, Brian
    Kaplan, Alexander
    Subramanian, Megha
    Jain, Aarushi
    Kumar, Swaminathan
    Danish, Husain
    White, Michael
    Shahid, Osmaan
    Pauken, Kristen E.
    Miller, Brian C.
    Frederick, Dennie T.
    Hebert, Christine
    Shaw, McKenzie
    Martinez-Lage, Maria
    Frosch, Matthew
    Wang, Nancy
    Gerstner, Elizabeth
    Nahed, Brian, V
    Curry, William T.
    Carter, Bob
    Cahill, Daniel P.
    Boland, Genevieve Marie
    Izar, Benjamin
    Davies, Michael A.
    Sharpe, Arlene H.
    Suva, Mario L.
    Sullivan, Ryan J.
    Brastianos, Priscilla K.
    Carter, Scott L.
    CANCER IMMUNOLOGY RESEARCH, 2022, 10 (08) : 996 - 1012
  • [22] Impact of immune checkpoint inhibition combined with stereotactic radiotherapy in treatment of brain metastases
    Khedkar, Sonal
    Kennedy, Andrew S.
    Hunt, D. Edward
    Gray, James
    Johnson, Melissa L.
    Chollet-Lipscomb, Casey
    McKean, Meredith
    Stevens, Brian J.
    Spigel, David
    CANCER RESEARCH, 2020, 80 (16)
  • [23] Inhibition of checkpoint kinase 1 sensitizes lung cancer brain metastases to radiotherapy
    Yang, Heekyoung
    Yoon, Su Jin
    Jin, Juyoun
    Choi, Seung Ho
    Seol, Ho Jun
    Lee, Jung-Il
    Nam, Do-Hyun
    Yoo, Hae Yong
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2011, 406 (01) : 53 - 58
  • [24] Advanced Magnetic Resonance Imaging Techniques in Management of Brain Metastases
    Mehrabian, Hatef
    Detsky, Jay
    Soliman, Hany
    Sahgal, Arjun
    Stanisz, Greg J.
    FRONTIERS IN ONCOLOGY, 2019, 9
  • [25] Local and distant brain control in melanoma and NSCLC brain metastases with concurrent radiosurgery and immune checkpoint inhibition
    Le, Amy
    Mohammadi, Homan
    Mohammed, Toka
    Burney, Heather
    Zang, Yong
    Frye, Douglas
    Shiue, Kevin
    Lautenschlaeger, Tim
    Miller, James
    JOURNAL OF NEURO-ONCOLOGY, 2022, 158 (03) : 481 - 488
  • [26] Local and distant brain control in melanoma and NSCLC brain metastases with concurrent radiosurgery and immune checkpoint inhibition
    Amy Le
    Homan Mohammadi
    Toka Mohammed
    Heather Burney
    Yong Zang
    Douglas Frye
    Kevin Shiue
    Tim Lautenschlaeger
    James Miller
    Journal of Neuro-Oncology, 2022, 158 : 481 - 488
  • [27] Breast cancer grade and clinical benefit in patients with advanced breast cancer treated with an engineered whole tumor cell-targeted immunotherapy alone or in combination with checkpoint inhibition.
    Williams, William
    Dakhil, Shaker R.
    Calfa, Carmen Julia
    Holmes, Jarrod P.
    Bhattacharya, Saveri
    Lukas, Jason Jerome
    Tan-Chiu, Elizabeth
    Peoples, George Earl
    Sunkari, Vivekananda
    Lacher, Markus
    Wiseman, Charles L.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [28] Impact of Brain Metastases in Immune Checkpoint Inhibitors (ICI) Treated Advanced Non-Small Cell Lung Cancer (NSCLC) Patients
    Hendriks, L.
    Henon, C.
    Auclin, E.
    Mezquita, L.
    Ferrara, R.
    Audigier-Valette, C.
    Mazieres, J.
    Lefebyre, C.
    Le Moulec, S.
    Cousin, S.
    Duchemann, B.
    Le Pechoux, C.
    Botticella, A.
    Ammari, S.
    Gazzah, A.
    Caramella, C.
    Adam, J.
    Planchard, D.
    De Ruysscher, D.
    Dingemans, A.
    Besse, B.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S384 - S384
  • [29] Improved Outcomes in Patients with Melanoma Brain Metastases Treated with Whole-Brain Radiation and Immune Checkpoint Inhibitors
    Cannon, D. M.
    Burt, L. M., Jr.
    Voorhies, B. N.
    Hitchcock, Y. J.
    Shrieve, D. C.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (01): : E72 - E72
  • [30] Association of inherited genetic variation with clinical outcome in patients with advanced renal cell carcinoma treated with mTOR inhibition.
    Pomerantz, Mark M.
    Gray, Kathryn P.
    Augusto, Fabio
    Schutz, Barros
    Percy, Andrew
    Lampron, Megan
    Signoretti, Sabina
    Hirsch, Michelle S.
    Rosenberg, Jonathan E.
    Lee, Gwo-Shu Mary
    McDermott, David F.
    Atkins, Michael B.
    Kantoff, Philip W.
    Freedman, Matthew L.
    Choueiri, Toni K.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)